CW March 2001
Volume 10Issue Number 3 March 2001 ISSN 10593802 Breast Cancer Drug Aimed at a Molecular TargetA monoclonal antibody that blocks the function of a growth factor receptor protein in breast cancer cell can effectively reduce tumor growth in those patients who produce excessive amount of the receptor protein.
Go to Previous Page Go to Next Page Source & Additional Reading D. J. Slamon et al., New England Journal of Medicine, March 15, 2001. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW March 2001Purchase Downloadable Full-text PDF of Complete Issue: $10.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
